Chen Guang Yan
Vorsitzender bei Chengdu Hepatunn Pharmaceutical Co. Ltd.
Profil
Mr. Chen Guang Yan is Deputy General Manager at Shenzhen Hepalink Pharmaceutical Co., Ltd.
and Chairman at Chengdu Haitong Pharmaceutical Co. Ltd.
He received his undergraduate degree from Peking University.
Aktive Positionen von Chen Guang Yan
Unternehmen | Position | Beginn |
---|---|---|
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Vorsitzender | - |
Ehemalige bekannte Positionen von Chen Guang Yan
Unternehmen | Position | Ende |
---|---|---|
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Corporate Officer/Principal | 16.05.2014 |
Ausbildung von Chen Guang Yan
Peking University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Process Industries |